Quality of life (QoL) improvements in patients with lower limb spasticity following treatment with abobotulinumtoxinA: Assessment using a disease-specific and a generic QoL instrument E-posterBy ISPRM2529 October, 2025
Botulinum Toxin Treatment in the Management of Post stroke Patients Undergoing Functional Surgery: A Retrospective Study E-posterBy ISPRM2517 October, 2025
Botulinum toxin underuse in older stroke survivors with spasticity: a nationwide population-based cohort study E-posterBy ISPRM2517 October, 2025
Identifying and Managing Spasticity in Neurological Shoulder Dysfunction E-posterBy ISPRM2517 October, 2025
EFFECT OF EARLY USE OF BOTULINUM TOXIN A ON GOAL ATTAINMENT IN POST-STROKE SPASTICITY E-posterBy ISPRM256 October, 2025
Spasticity Predictive Factors of inpatients with Stroke diagnosis during their hospitalization in a Rehabilitation Clinic. E-posterBy ISPRM256 October, 2025
SPASTICITY AND CLONUS MANAGEMENT OF OUTPATIENT MULTIPLE SCLEROSIS PATIENTS WITH BOTULINUM TOXIN A REHABILITATION CENTER E-posterBy ISPRM256 October, 2025
Feasibility and Comprehensibility of the SMD Decision Tree for Early Recognition of Spasticity E-posterBy ISPRM256 October, 2025
SOLUTION Study: A New Approach for Lower Limb Spasticity Post-Stroke Using Shock Wave Therapy and Botulinum Toxin – A Pilot Randomized Clinical Trial E-posterBy ISPRM2523 September, 2025
An Audit of Botulinum Neurotoxin usage at the National Rehabilitation Hospital, Ireland E-posterBy ISPRM2523 September, 2025